Chun‐Hui Su

698 total citations
9 papers, 411 citations indexed

About

Chun‐Hui Su is a scholar working on Molecular Biology, Oncology and Cell Biology. According to data from OpenAlex, Chun‐Hui Su has authored 9 papers receiving a total of 411 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Molecular Biology, 5 papers in Oncology and 2 papers in Cell Biology. Recurrent topics in Chun‐Hui Su's work include Ubiquitin and proteasome pathways (6 papers), Cancer-related Molecular Pathways (5 papers) and 14-3-3 protein interactions (3 papers). Chun‐Hui Su is often cited by papers focused on Ubiquitin and proteasome pathways (6 papers), Cancer-related Molecular Pathways (5 papers) and 14-3-3 protein interactions (3 papers). Chun‐Hui Su collaborates with scholars based in United States, China and Taiwan. Chun‐Hui Su's co-authors include Mong‐Hong Lee, Sai‐Ching J. Yeung, Liem Phan, Xiaochun Zhang, Jian Chen, Hyun Ho Choi, Guermarie Velázquez-Torres, Fanmao Zhang, Ping‐Chieh Chou and Jiun‐Sheng Chen and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Cancer Research and Molecular Cancer.

In The Last Decade

Chun‐Hui Su

9 papers receiving 408 citations

Peers

Chun‐Hui Su

MB

ONCOL

CB

CR

PS

Gérald Lossaint France

Sabrina F. Mansilla Argentina

Ruth Thompson United States

Tovah A. Day United States

Pedro Zuazua‐Villar United Kingdom

Justin Moser United States

Xiangzi Han United States

Yuko Katsuno Japan

Heidrun Hirner Germany

Katie Ridd United States

Gérald Lossaint France

Chun‐Hui Su

332 ×1.0

MB

143 ×0.8

ONCOL

69 ×0.6

CB

72 ×0.8

CR

20 ×0.8

PS

Citations per year, relative to Chun‐Hui Su Chun‐Hui Su (= 1×) peers Gérald Lossaint

Countries citing papers authored by Chun‐Hui Su

Since Specialization

Citations

This map shows the geographic impact of Chun‐Hui Su's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Chun‐Hui Su with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Chun‐Hui Su more than expected).

Fields of papers citing papers by Chun‐Hui Su

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Chun‐Hui Su. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Chun‐Hui Su. The network helps show where Chun‐Hui Su may publish in the future.

Co-authorship network of co-authors of Chun‐Hui Su

This figure shows the co-authorship network connecting the top 25 collaborators of Chun‐Hui Su. A scholar is included among the top collaborators of Chun‐Hui Su based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Chun‐Hui Su. Chun‐Hui Su is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

9 of 9 papers shown

1.

Choi, Hyun Ho, Liem Phan, Ping‐Chieh Chou, et al.. (2015). COP1 enhances ubiquitin-mediated degradation of p27Kip1 to promote cancer cell growth. Oncotarget. 6(23). 19721–19734. 25 indexed citations

2.

Choi, Hyun Ho, Chun‐Hui Su, Lekun Fang, et al.. (2015). CSN6 deregulation impairs genome integrity in a COP1-dependent pathway. Oncotarget. 6(14). 11779–11793. 13 indexed citations

3.

Wei, Caimiao, et al.. (2014). Indole-3-carbinol and its N-alkoxy derivatives preferentially target ER α -positive breast cancer cells. Cell Cycle. 13(16). 2587–2599. 38 indexed citations

4.

Zhao, Ruiying, Heng-Yin Yang, Ji‐Hyun Shin, et al.. (2013). CDK inhibitor p57^Kip2 is downregulated by Akt during HER2-mediated tumorigenicity. Cell Cycle. 12(6). 935–943. 31 indexed citations

5.

Velázquez-Torres, Guermarie, Ji-Hyun Shin, Enrique Fuentes‐Mattei, et al.. (2012). Aurora B kinase phosphorylates and instigates degradation of p53. Proceedings of the National Academy of Sciences. 109(24). E1513–22. 143 indexed citations

6.

Su, Chun‐Hui, Ruiying Zhao, Fanmao Zhang, et al.. (2010). 14-3-3σ Exerts Tumor-Suppressor Activity Mediated by Regulation of COP1 Stability. Cancer Research. 71(3). 884–894. 50 indexed citations

7.

Su, Chun‐Hui, Ruiying Zhao, Guermarie Velázquez-Torres, et al.. (2010). Nuclear export regulation of COP1 by 14-3-3σ in response to DNA damage. Molecular Cancer. 9(1). 243–243. 38 indexed citations

8.

Zhang, Xiaochun, et al.. (2007). Roles for CSN5 in control of p53/MDM2 activities. Journal of Cellular Biochemistry. 103(4). 1219–1230. 71 indexed citations

9.

Su, Chun‐Hui, et al.. (2007). Increased expression of nuclear NF-kappaB after coronary artery balloon injury can be inhibited by intracoronary beta-irradiation. International Journal of Radiation Biology. 83(10). 707–716. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact